Targeted Vessel Tech FLEX Vascular specializes in vessel preparation and drug delivery for AV access and peripheral vascular disease, presenting a clear opportunity to position advanced interventional devices to centers performing frequent AV fistula and PAD procedures.

High Growth Potential With revenue between 1M-10M and a substantial funding round of 66M, FLEX Vascular shows scale potential and readiness for expanded sales initiatives, partnerships, or multi-site trials with hospital systems and vascular centers.

Strategic Partnerships Founded by a vascular surgeon and now operating as Flex Vascular, the company may value collaboration with specialty distributors, key opinion leaders, and academic centers to validate KEMIC and accelerate adoption in interventional suites.

Competitive Positioning In a market with large incumbents, FLEX Vascular’s focus on cost-effective vessel preparation and improved outcomes can be leveraged to differentiate in discussions with large hospital networks seeking value-based procurement.

Digital & Training Expansion Current tech stack and global reach imply opportunities to offer training programs, clinical education partnerships, and digital marketing to raise awareness among interventionalists about KEMIC capabilities and patient outcomes.